How Much Is a Dexcom? Prices With and Without Insurance

A Dexcom continuous glucose monitor runs roughly $300 to $400 per month without insurance, depending on the model and where you buy it. With commercial insurance or Medicare, most people pay far less, and some pay nothing beyond a small copay. But those headline numbers obscure a lot of variation driven by plan type, pharmacy versus durable medical equipment billing, and whether you qualify for one of several discount programs. The real cost picture involves more moving parts than most people expect when they first ask the question.

What You’re Actually Paying For

Dexcom sells a system, not a single device. The current flagship model, the Dexcom G7, uses a small sensor that attaches to your skin and reads glucose levels in the fluid just beneath it. Each sensor lasts about 10 days, so you go through roughly three per month. With the G7, the transmitter is built into each disposable sensor, which simplified things compared to older models that required a separate reusable transmitter. You also need something to display the readings: either a compatible smartphone, which most people already own, or an optional standalone receiver that costs a couple hundred dollars.

The ongoing expense is the sensors themselves. A 30-day supply, meaning three sensors, is the recurring cost you need to budget for. Everything else, including the app and cloud-based data sharing with your doctor, is included. If you’re comparing Dexcom to its competitors, the monthly sensor cost is the apples-to-apples number that matters.

Cash Prices Without Insurance

If you’re paying entirely out of pocket, a month’s supply of Dexcom G7 sensors typically lands between $300 and $400 at a retail pharmacy. The exact price swings depending on the pharmacy chain and your location. Some people find slightly lower prices through mail-order pharmacies or by ordering directly from Dexcom. Over a full year, that adds up to roughly $3,600 to $4,800, which is a substantial expense by any measure.

Dexcom also introduced the Stelo, an over-the-counter glucose biosensor aimed at people with type 2 diabetes who don’t use insulin, or people with prediabetes who want to track how their diet and exercise affect blood sugar. The Stelo runs about $89 to $99 per month without a prescription. It’s a meaningfully cheaper entry point, though it’s designed for a different use case than the G7 and lacks some features like urgent low glucose alerts that insulin users depend on.

For context, the traditional alternative to a continuous monitor is fingerstick testing with a standard glucose meter. Test strips cost a few dollars per day for someone checking four to six times daily, so the annual expense for frequent fingerstick testing often runs $1,500 to $2,500 depending on the brand and how often you test. The gap between that and a Dexcom isn’t as dramatic as it first appears, especially once you factor in the clinical benefits of continuous data and fewer surprise emergency visits.

What Insurance Typically Covers

Most commercial insurance plans now cover continuous glucose monitors for people with type 1 diabetes, and coverage for type 2 diabetes has expanded considerably in recent years. What you actually pay depends on your plan’s copay, coinsurance, and deductible structure, and on whether your plan classifies the sensor as a pharmacy benefit or as durable medical equipment. That distinction matters because pharmacy benefits often have simpler copay structures, while durable medical equipment can involve a percentage-based coinsurance that leaves you responsible for 20% or more of the allowed amount.

Under a pharmacy benefit, many people with commercial insurance pay somewhere between $20 and $75 per month for their Dexcom sensors after a copay. Under a durable medical equipment benefit, you might owe a coinsurance percentage until you hit your plan’s out-of-pocket maximum. Either way, the insured price is dramatically lower than cash pay. Some plans, particularly those offered by large employers with generous formularies, cover Dexcom at $0 copay.

The catch is that most insurers require prior authorization. Your doctor needs to submit paperwork showing you meet certain criteria, which usually include a diabetes diagnosis, a history of blood sugar monitoring, and evidence that continuous monitoring is medically necessary. For type 1 diabetes, approval is generally straightforward. For type 2, some plans still push back, particularly if you don’t use insulin. That said, the trend is clearly toward broader coverage as the evidence base grows.

Medicare, Medicaid, and Their Quirks

Medicare Part B covers continuous glucose monitors as durable medical equipment, and Dexcom is among the approved devices. Beneficiaries typically owe 20% coinsurance after meeting their Part B deductible, which means monthly out-of-pocket costs in the range of $30 to $60 for most people. If you have a Medigap supplemental plan, it may cover that remaining 20%, dropping your cost to zero or close to it.

Medicare’s eligibility rules, however, are narrower than the science supports. Coverage generally requires that you use insulin, that you check your blood sugar frequently, and that your insulin regimen needs adjustment based on CGM data. A critical review of these criteria concluded that they ignore strong evidence supporting CGM use in diabetes populations that Medicare currently deems ineligible, leaving some people who would clearly benefit without coverage for the device.¹ If you have type 2 diabetes managed with oral medications alone, for instance, Medicare is unlikely to cover a Dexcom even though research increasingly suggests it would help.

Medicaid coverage varies by state. Some state Medicaid programs cover CGMs with minimal copays, while others restrict access to certain diabetes populations or require extensive prior authorization. If you’re on Medicaid, your best first step is calling your state’s Medicaid line or checking with a diabetes educator who knows your state’s specific formulary.

How to Lower the Cost

Several programs can chip away at what you pay, even if you have insurance with a high copay or no coverage at all.

Dexcom savings card: Dexcom offers a copay assistance program for commercially insured patients that can reduce monthly sensor costs to as little as $20 to $40. The first fill is sometimes free. This card doesn’t work with government insurance like Medicare or Medicaid.
Manufacturer patient assistance: Dexcom’s own assistance program provides free devices and sensors to people who are uninsured or underinsured and meet income criteria. Eligibility usually requires being below a certain percentage of the federal poverty level.
HSA and FSA accounts: If you’re in a high-deductible health plan, you can pay for Dexcom sensors with pre-tax dollars from a health savings account or flexible spending account. That effectively saves you whatever your marginal tax rate is, which for many people means a 22% to 32% discount on the sticker price.
Pharmacy discount programs: Third-party discount cards like those from GoodRx or RxSaver sometimes offer negotiated rates that beat the cash price at certain pharmacies, though the savings for a brand-name CGM sensor are less dramatic than for generic medications.

Research on high-deductible plans with health savings accounts has shown that when preventive medications get moved to a reduced cost-sharing tier, patients’ out-of-pocket drug spending drops by about 35%, and medication use goes up, with the biggest gains for lower-income patients.² The takeaway is that if your plan categorizes CGM supplies as preventive, or if your employer moves them to a lower cost-sharing tier, you could see a meaningful reduction in what you pay each month.

Hidden Costs and Sensor Replacement

The listed price covers the sensors, but a few additional costs catch people off guard. If you prefer the standalone Dexcom receiver instead of using your phone, that’s an upfront cost. Skin adhesive patches or overtapes, which many people use to keep sensors firmly in place during exercise or in humid weather, cost a few dollars per sensor. These seem trivial individually, but they add up over a year of continuous wear.

The bigger hidden cost involves sensor failures and early replacements. Each Dexcom G7 sensor is rated for about 10 days. In practice, a study of young people with type 1 diabetes found the median real-world wear time was about 8.6 days, and that youth would need roughly 43 sensors per year rather than the standard 36 to maintain continuous coverage.³ Sensors sometimes fall off early, malfunction, or give unreliable readings that prompt removal ahead of schedule. Dexcom will replace sensors that fail prematurely at no charge if you contact support, but there’s a gap period where you might need an extra sensor on hand, and insurance doesn’t always cover more than 36 per year. Adults tend to get closer to the full 10 days per sensor, so this issue is more pronounced for children and teenagers.

Whether the Cost Is Worth It Over Time

Price tag aside, the economic question most people really want answered is whether a Dexcom pays for itself by preventing expensive complications down the road. For type 1 diabetes, the evidence is fairly clear. A systematic review of cost-effectiveness studies found that continuous glucose monitoring consistently came out as cost-effective compared to fingerstick testing, with the savings driven mainly by fewer short-term emergencies like severe low blood sugar episodes and fewer long-term complications like kidney disease and nerve damage.⁴ The device was most cost-effective in people whose blood sugar control was poor or who had a history of dangerous lows.

For type 2 diabetes, the picture has become increasingly favorable. A modeling study looked at people with type 2 diabetes on basal insulin and found that continuous glucose monitoring actually saved money over a ten-year period compared to fingerstick testing: total costs were lower with CGM, at about $70,100 versus $71,800, while also delivering better health outcomes. The roughly $10,500 increase in monitoring costs was more than offset by about $12,100 in avoided treatment costs, with the biggest savings coming from reduced kidney failure, fewer heart attacks, and fewer episodes of severe low blood sugar and diabetic ketoacidosis.⁵ In that analysis, CGM had a 100% probability of being cost-effective at standard economic thresholds.

This doesn’t mean a Dexcom is a slam-dunk financial win for every individual. If your blood sugar is already well-controlled with minimal effort and you’re at low risk for severe lows, the upfront cost buys you less avoided-complication value. But if you struggle with unpredictable glucose swings, experience hypoglycemia that sends you to the ER, or have complications that are getting worse, the long-term economics tilt heavily in favor of continuous monitoring. A single hospital admission for severe hypoglycemia or diabetic ketoacidosis can easily cost $10,000 to $30,000, which is several years’ worth of sensor costs.

How Dexcom Pricing Compares to Other CGMs

Dexcom isn’t the only continuous glucose monitor on the market. Abbott’s FreeStyle Libre system is the most direct competitor and is generally cheaper, with monthly sensor costs that tend to run $50 to $150 less than Dexcom depending on the specific model and insurance plan. The Libre uses a factory-calibrated sensor that lasts 14 days rather than 10, so you need fewer sensors per month. The trade-off is that older Libre models required you to actively scan the sensor to get a reading, though newer versions now offer continuous real-time alerts similar to Dexcom.

Medtronic also makes continuous glucose monitors, but they’re primarily designed to work as part of Medtronic’s integrated insulin pump systems rather than as standalone devices, so pricing comparisons are more complicated. For someone shopping purely for a standalone CGM, the realistic choice usually comes down to Dexcom or Libre, and the decision often hinges on which device your insurance covers at a better tier, plus your personal preference for features like real-time sharing with family members, alarm customization, and integration with insulin pumps from multiple manufacturers.

If cost is the primary concern and you have type 2 diabetes without insulin use, the Dexcom Stelo and the Libre system occupy a similar over-the-counter space, both in the neighborhood of $75 to $100 per month. Neither requires a prescription in their OTC configurations, which eliminates the prior authorization headache entirely, though it also means insurance generally won’t reimburse you.

When a Prescription CGM Gets Treated as Preventive

An emerging development worth watching is the push to classify continuous glucose monitors as preventive care under the Affordable Care Act’s preventive services framework. If CGMs were formally designated as preventive for certain populations, insurers would be required to cover them with zero cost-sharing, the same way they cover blood pressure screenings and certain vaccines. That hasn’t happened yet at a federal level, but some individual insurers and employer plans have already moved CGM supplies into a preventive or preferred tier voluntarily.

The preventive-tier shift matters most for people on high-deductible health plans. Normally, you’d have to pay full price for sensors until you meet your annual deductible, which can be $1,500 to $3,000 or more for an individual. If your plan classifies CGM supplies as preventive, they’re covered before the deductible kicks in. Given that the cost-effectiveness research increasingly shows CGM prevents expensive complications, the argument for preventive classification is strong, and some policymakers and diabetes advocacy groups are actively pushing for it. The practical effect for you would be going from potentially paying several thousand dollars out of pocket early in the plan year to paying little or nothing from day one.

For now, the best way to find out how your specific plan handles CGM coverage is to call the number on the back of your insurance card and ask two questions: whether continuous glucose monitors are covered, and whether they’re classified as pharmacy, durable medical equipment, or preventive. That single phone call can save you from billing surprises and help you route your prescription through whichever pathway gives you the lowest cost.